Henry Meds is a large, well-known compounded-GLP-1 platform with a low-friction asynchronous intake on the 503A pathway. Compounded; not FDA-approved. Figures verified July 2026 — confirm current pricing with the provider.
Henry Meds is a large, well-known compounded-GLP-1 platform with a low-friction asynchronous intake on the 503A pathway. Compounded; not FDA-approved.
Oversight: clinician + async intake. Medication type: compounded tirzepatide. As with any provider, eligibility and any prescription are determined by a licensed clinician and are not guaranteed.
On our methodology, our #1 pick (NexLife) leads on pricing transparency and pharmacy disclosure. Henry Meds may be the better fit depending on whether you want a brand-name product, insurance billing, or a particular care model. Compare directly on the price comparison and full rankings.